About DeepenDrugs
DeepenDrugs is a Healthcare company based in Ahmedabad (India) founded in 1982. Wholesale trading of APIs, excipients, chemicals, solvents, nutraceuticals. It operates on a B2B model. The company has 1 employees. Its Indian entity Deependrugs Private Limited reported revenue of ₹17.68 Cr. DeepenDrugs offers products and services including ACECLOFENAC, BROMHEXINE, CYPROHEPTEDIN, DIACEREIN, and ETORICOXIB. Its focus areas include Nutraceuticals, Supplements, Food Supplements and Pharmaceuticals. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
DeepenDrugs Pvt. Ltd., established in 1982 in Ahmedabad, India, specializes in sourcing and supplying active pharmaceutical ingredients, excipients, chemicals, solvents, and nutraceuticals. The company operates as a wholesale trader, focusing on the pharmaceutical industry with a team-based approach to meet industry needs. It serves clients in the healthcare sector through reliable product distribution and expertise.
- Headquarters Ahmedabad, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website deependrugs.in
- Legal Name Deependrugs Private Limited
- Date of Incorporation 23 May, 2020
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹17.68 Cr
FY 2025 · -30% YoY
- Net Profit₹3.6 Lakh
FY 2025 · 0% margin
- EBITDA₹39.8 Lakh
FY 2025 · 2% margin
- Employee Count1
Associated legal entities of DeepenDrugs
DeepenDrugs operates through Deependrugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Deependrugs Private Limited CIN U24304GJ2020PTC113643 | Active | 23 May 2020 | Ahmedabad, Gujarat | ₹17.7 Cr | 2 | View details |
Products & Services of DeepenDrugs
DeepenDrugs offers a comprehensive portfolio of products and services, including ACECLOFENAC, BROMHEXINE, CYPROHEPTEDIN, DIACEREIN, and ETORICOXIB.
Active ingredient used for anti-inflammatory treatments.
Mucolytic agent for respiratory condition management.
Medication for appetite stimulation and allergy relief.
Compound for osteoarthritis and joint health support.
Anti-inflammatory drug for pain and inflammation control.
Antipsychotic medication for mental health disorders.
Acid reducer for gastrointestinal condition treatment.
Antibiotic for parasitic and bacterial infections.
Board of directors of Deependrugs Private Limited (DeepenDrugs)
Deependrugs Private Limited is the primary company behind DeepenDrugs. The board of Deependrugs Private Limited currently have 2 directors; the longest-serving is Sandip Shaileshbhai Shah, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sandip Shaileshbhai Shah DIN 02365284 | Director | 23 May 2020 | 6 yrs 5 mo | Deependrugs Private Limited |
| Rupen Shaileshkumar Shah DIN 01178019 | Director | 23 May 2020 | 6 yrs 5 mo | Deependrugs Private Limited |
Financials of DeepenDrugs
Figures of Deependrugs Private Limited, the primary company behind DeepenDrugs, for FY 2025. Revenue was ₹17.68 Cr (-30% year on year). Net profit was ₹3.6 Lakh (0% margin). EBITDA was ₹39.8 Lakh (2% margin). Revenue has grown at a compounded annual rate of -17% over three years.
- ₹17.68 CrRevenue · FY 2025 · -30% YoY
- ₹3.6 LakhNet profit · 0% margin
- ₹39.8 LakhEBITDA · 2% margin
- ₹10 LakhPaid-up capital
- -17%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Deependrugs Private Limited are on its company page.
Detailed financial statements for DeepenDrugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to DeepenDrugs
DeepenDrugs has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of DeepenDrugs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as DeepenDrugs (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 55.41 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 56.21 M | 144 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DeepenDrugs
DeepenDrugs was founded in 1982.
DeepenDrugs is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
DeepenDrugs has 1 employees.
The primary company behind DeepenDrugs, Deependrugs Private Limited, reported revenue of ₹17.68 Cr for FY 2025, down 30% year on year.
DeepenDrugs Pvt. Ltd., established in 1982 in Ahmedabad, India, specializes in sourcing and supplying active pharmaceutical ingredients, excipients, chemicals, solvents, and nutraceuticals. The company operates as a wholesale trader, focusing on the pharmaceutical industry with a team-based approach to meet industry needs. It serves clients in the healthcare sector through reliable product distribution and expertise.
DeepenDrugs's top competitors include Laurus Labs, Symbiotec and SeQuent.
DeepenDrugs offers ACECLOFENAC, BROMHEXINE, CYPROHEPTEDIN, DIACEREIN, and 4 more products and services.
DeepenDrugs operates through Deependrugs Private Limited.
The legal entities of DeepenDrugs currently have 2 directors, including Sandip Shaileshbhai Shah, Rupen Shaileshkumar Shah.